These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 16968347)

  • 41. A SMART data analysis method for constructing adaptive treatment strategies for substance use disorders.
    Nahum-Shani I; Ertefaie A; Lu XL; Lynch KG; McKay JR; Oslin DW; Almirall D
    Addiction; 2017 May; 112(5):901-909. PubMed ID: 28029718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacotherapy for Adults With Alcohol Use Disorder.
    Bruehlman A; Salisbury-Afshar E
    Am Fam Physician; 2024 May; 109(5):459-462. PubMed ID: 38804761
    [No Abstract]   [Full Text] [Related]  

  • 43. An open-label naturalistic pilot study of acamprosate in youth with autistic disorder.
    Erickson CA; Early M; Stigler KA; Wink LK; Mullett JE; McDougle CJ
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):565-9. PubMed ID: 22136091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of Anti-Craving Agents in Soldiers with Alcohol Dependence Syndrome.
    Narayana PL; Gupta AK; Sharma PK
    Med J Armed Forces India; 2008 Oct; 64(4):320-4. PubMed ID: 27688567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
    Maisel NC; Blodgett JC; Wilbourne PL; Humphreys K; Finney JW
    Addiction; 2013 Feb; 108(2):275-93. PubMed ID: 23075288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.
    Jonas DE; Amick HR; Feltner C; Bobashev G; Thomas K; Wines R; Kim MM; Shanahan E; Gass CE; Rowe CJ; Garbutt JC
    JAMA; 2014 May; 311(18):1889-900. PubMed ID: 24825644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study.
    Mann K; Lemenager T; Hoffmann S; Reinhard I; Hermann D; Batra A; Berner M; Wodarz N; Heinz A; Smolka MN; Zimmermann US; Wellek S; Kiefer F; Anton RF;
    Addict Biol; 2013 Nov; 18(6):937-46. PubMed ID: 23231446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence.
    Sass H; Soyka M; Mann K; Zieglgänsberger W
    Arch Gen Psychiatry; 1996 Aug; 53(8):673-80. PubMed ID: 8694680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial.
    O'Malley SS; Robin RW; Levenson AL; GreyWolf I; Chance LE; Hodgkinson CA; Romano D; Robinson J; Meandzija B; Stillner V; Wu R; Goldman D
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1271-83. PubMed ID: 18482155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
    Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
    JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.
    Oslin DW; Lynch KG; Pettinati HM; Kampman KM; Gariti P; Gelfand L; Ten Have T; Wortman S; Dundon W; Dackis C; Volpicelli JR; O'Brien CP
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1299-308. PubMed ID: 18540910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
    Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
    Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
    Mann K; Bladström A; Torup L; Gual A; van den Brink W
    Biol Psychiatry; 2013 Apr; 73(8):706-13. PubMed ID: 23237314
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence.
    Petrakis IL; Ralevski E; Desai N; Trevisan L; Gueorguieva R; Rounsaville B; Krystal JH
    Neuropsychopharmacology; 2012 Mar; 37(4):996-1004. PubMed ID: 22089316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acamprosate for alcohol dependence.
    Rösner S; Hackl-Herrwerth A; Leucht S; Lehert P; Vecchi S; Soyka M
    Cochrane Database Syst Rev; 2010 Sep; (9):CD004332. PubMed ID: 20824837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness and safety of baclofen in the treatment of alcohol dependent patients.
    Leggio L; Garbutt JC; Addolorato G
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):33-44. PubMed ID: 20201813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Naltrexone effects on diazepam intoxication and pharmacokinetics in humans.
    Swift R; Davidson D; Rosen S; Fitz E; Camara P
    Psychopharmacology (Berl); 1998 Feb; 135(3):256-62. PubMed ID: 9498728
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disulfiram treatment of alcoholism. A Veterans Administration cooperative study.
    Fuller RK; Branchey L; Brightwell DR; Derman RM; Emrick CD; Iber FL; James KE; Lacoursiere RB; Lee KK; Lowenstam I
    JAMA; 1986 Sep; 256(11):1449-55. PubMed ID: 3528541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naltrexone: lack of effect on hepatic enzymes.
    Brahen LS; Capone TJ; Capone DM
    J Clin Pharmacol; 1988 Jan; 28(1):64-70. PubMed ID: 3350993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.